BIOS — Biosenic SA Cashflow Statement
0.000.00%
Last trade - 00:00- €1.63m
- €26.31m
Annual cashflow statement for Biosenic SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -17.4 | -12 | -2.32 | -7.04 | -5.21 |
| Depreciation | |||||
| Non-Cash Items | -2.18 | -1.42 | -0.001 | -0.307 | 2.57 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.94 | 0.473 | 0.349 | 3.63 | 0.226 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -16.1 | -12.8 | -1.91 | -3.47 | -2.22 |
| Capital Expenditures | -0.093 | -0.207 | -0.005 | — | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 12 | 0.003 | 1.96 | 0.006 | 0.031 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 11.9 | -0.204 | 1.95 | 0.006 | 0.031 |
| Financing Cash Flow Items | -3.83 | -1 | -0.203 | -0.304 | -0.39 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 10.2 | 7.85 | 1.04 | 1.74 | 2.46 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6.01 | -5.14 | 1.09 | -1.73 | 0.274 |